Literature DB >> 2190652

Interleukin-4. A regulatory protein.

J H Jansen1, W E Fibbe, R Willemze, J C Kluin-Nelemans.   

Abstract

Since its discovery in 1982, numerous biological activities of interleukin-4 (IL-4) have been described. Like other cytokines, IL-4 is highly pleiotropic, both with respect to the number of different target cells that are responsive to it and with respect to the number of different biological responses it elicits. Interleukin-4 was initially described as a costimulant for the proliferation of B lymphocytes stimulated with anti-IgM antibody. Synonyms for this cytokine are B cell growth factor-1 (BCGF-1) and B cell stimulatory factor-1 (BSF-1). After cloning of both the murine and human IL-4, the use of recombinant IL-4 enabled detailed studies of its biological functions. Many cell types, mainly of hematological origin, express receptors for IL-4. Accordingly, effects of IL-4 have been described on B lymphocytes, T lymphocytes, NK cells, mononuclear phagocytes, mast cells, fibroblasts and hematopoietic progenitor cells. Currently, there are three major areas in which IL-4 appears to play an important role: 1) regulation of B cell growth and of antibody isotype expression. In this context, a possible role for IL-4 in allergic reactions is of special interest. 2) Stimulation of T cell growth and the generation of cytotoxic T lymphocytes. In addition to the suppressive effects on the induction of non HLA-restricted cellular cytotoxicity by natural killer- (NK) and lymphokine-activated killer (LAK) cells, this suggests a role for IL-4 in the regulation of cellular immune responses. 3) Regulation of the growth and differentiation of hematopoietic bone marrow stem cells. IL-4 itself does not induce proliferation of hematological progenitor cells but it can modulate the growth-factor dependent proliferation of these cells. In this review the biological functions of IL-4, reported until present, are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190652     DOI: 10.1007/bf01736226

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  79 in total

1.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Mitogen- and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switching.

Authors:  S Lutzker; P Rothman; R Pollock; R Coffman; F W Alt
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

3.  Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.

Authors:  F Rousset; R W Malefijt; B Slierendregt; J P Aubry; J Y Bonnefoy; T Defrance; J Banchereau; J E de Vries
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

4.  Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.

Authors:  H E Broxmeyer; L Lu; S Cooper; R Tushinski; D Mochizuki; B Y Rubin; S Gillis; D E Williams
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression.

Authors:  N Arai; D Nomura; D Villaret; R DeWaal Malefijt; M Seiki; M Yoshida; S Minoshima; R Fukuyama; M Maekawa; J Kudoh
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

6.  Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.

Authors:  C M Snapper; W E Paul
Journal:  Science       Date:  1987-05-22       Impact factor: 47.728

7.  Recombinant interleukin 4 promotes the growth of human T cells.

Authors:  H Spits; H Yssel; Y Takebe; N Arai; T Yokota; F Lee; K Arai; J Banchereau; J E de Vries
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

8.  Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells.

Authors:  D Rennick; G Yang; C Muller-Sieburg; C Smith; N Arai; Y Takabe; L Gemmell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.

Authors:  A Zlotnik; M Fischer; N Roehm; D Zipori
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

10.  Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1).

Authors:  P M Stuart; A Zlotnik; J G Woodward
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  8 in total

Review 1.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 2.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

3.  IL-4 down-regulates IL-2-, IL-3-, and GM-CSF-induced cytokine gene expression in peripheral blood monocytes.

Authors:  F H Cluitmans; B H Esendam; J E Landegent; R Willemze; J H Falkenburg
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

4.  Opioid-like activity of naltrexone on natural killer cell cytolytic activity and cytokine production in splenocytes: effects of alcohol.

Authors:  Nadka I Boyadjieva; Dipak K Sarkar
Journal:  J Interferon Cytokine Res       Date:  2010-01       Impact factor: 2.607

5.  Lack of effects of recombinant human interleukin-4 on in vitro colony formation of freshly explanted human tumor cells.

Authors:  A R Hanauske; D Degen; M H Marshall; P P Trotta; D D Von Hoff
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

6.  Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.

Authors:  A Thanhäuser; N Reiling; A Böhle; K M Toellner; M Duchrow; D Scheel; C Schlüter; M Ernst; H D Flad; A J Ulmer
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

7.  In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway disease.

Authors:  J Youn; J Chen; S Goenka; M A Aronica; A L Mora; V Correa; J R Sheller; M Boothby
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

8.  Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).

Authors:  M F Tungekar; K C Gatter; M A Ritter
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.